Quantcast

Latest Actinic keratosis Stories

2009-10-28 05:30:00

WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that global sales volumes of the Levulan® Kerastick®, an integral part of the Levulan® Photodynamic Therapy (PDT) technology platform, surpassed one million units. "The achievement of this milestone signifies that dermatologists in the U.S. and...

2009-10-23 08:00:00

BRISTOL, Tenn., Oct. 23 /PRNewswire/ -- Driver Aric Almirola is lending his voice to a national public education program to raise awareness of actinic keratosis (AK) -- a potential early warning sign of skin cancer -- as well as the long-term consequences of sun damage over a lifetime. The national campaign, "Is it AK or OK?" is sponsored by Graceway Pharmaceuticals, LLC, in partnership with The Skin Cancer Foundation. Graceway is the primary sponsor of the No. 15 NASCAR Camping...

2009-10-21 05:30:00

Second Consecutive Year DUSA Has Been Recognized WILMINGTON, Mass., Oct. 21 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R)( )(Nasdaq: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that it has been named to Deloitte's Technology Fast 500 list. For the second consecutive year, Deloitte recognized DUSA as one of the Top 500 fastest growing technology, media, telecommunications and life sciences companies in North America in terms of...

2009-09-02 07:30:00

WILMINGTON, Mass., Sept. 2 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R) (Nasdaq: DUSA), a dermatology company that is developing and marketing Levulan(R) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 11th Annual Healthcare Conference on Wednesday, September 9, 2009 at 4:30 p.m. EDT at The New York...

2009-08-06 05:30:00

WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA) announces that its corporate highlights and second quarter financial results press release will be issued on Tuesday, August 11 at 6:30 a.m. to be followed by a conference call at 8:30 a.m. Tuesday, August 11 - 8:30 a.m. E.T. If calling from the US or Canada use the following toll-free number: 800.647.4314 Password - DUSA For International callers use 502.498.8422 A recorded replay of the...

2009-06-17 09:25:57

 A relatively inexpensive cream made from a chemotherapy medication used to treat cancers of the colon, head and neck and pancreas significantly reduced age-related skin damage in 21 healthy volunteers. The medication, Fluorouracil, appears to reduce potentially precancerous skin patches and improve the appearance of sun-damaged skin.In early studies of cancer patients undergoing treatment with systemic Fluorouracil, clinicians noticed changes in skin appearance, which led to the...

4382115a6644b765254622dcbf5ce5611
2009-06-16 12:55:00

Researchers have found that a cream first introduced as a treatment for the early signs of skin cancer may also smooth wrinkles and rough spots, improve color and erase brown spots to reveal a more youthful appearance. The cream Efudex is produced by Valeant Pharmaceuticals for the treatment of a precancerous form of squamous cell carcinoma known as actinic keratoses. Dr. Dana Sachs of the University of Michigan, whose study appears in the Archives of Dermatology, said the cream appears to be...

02e214d57361cef8ebc2ab3c0609bfff1
2009-06-03 08:05:00

Actinic keratoses are sun-damaged rough patches or lesions on the skin "” often pink and scaly "” that doctors have long believed can turn into a form of skin cancer known as squamous cell carcinoma.Now researchers at Brown University, the Veterans Administration Medical Centers in Providence and Oklahoma City, and others have determined that actinic keratoses appear responsible for a larger spectrum of skin cancers than previously thought. Their research is highlighted in the...

2008-10-23 09:00:39

Dusa Pharmaceuticals, an integrated dermatology pharmaceutical company, has announced results from its Phase IIb clinical trial to compare the safety and efficacy of photodynamic therapy using the company's Blu-U brand light plus vehicle containing Levulan to that of photodynamic therapy using the Blu-U plus vehicle without Levulan in patients with moderate to severe facial acne vulgaris. The study has demonstrated a statistically significant reduction in the number of inflammatory lesions...

3c7af3e6af5bb89f0cb35b1e5e7454a21
2008-10-21 13:10:00

Looking for youthful skin? Researchers announced on Monday that a process of using a topical solution made by the company DUSA Pharmaceuticals Inc and laser treatment encourages collagen production and helps revitalize skin that was damaged by the sun. Their study established the importance of the procedure, currently being performed by doctors, that recovers the look of skin with wrinkles, fine lines and "sun spots", and explains how the procedure works. University of Michigan researchers...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related